Evotec SE (EVO) Cash from Operations Growth (1y) (2010 - 2026)
Powered by 
Analysis
Evotec SE (EVO) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 25.96% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 9.08% |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | -12.16% |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 92.39% |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 32.57% |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | -9.98% |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | -129.09% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | -119.28% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 86.30% |
| Dec 31, 2025 | -107.71% |
| Sep 30, 2025 | -268.82% |
| Jun 30, 2025 | 155.36% |
| Mar 31, 2025 | 36.07% |
| Dec 31, 2024 | 269.60% |
| Jun 30, 2024 | -704.12% |
| Mar 31, 2024 | -7,889.36% |
| Dec 31, 2023 | 168.24% |
| Jun 30, 2023 | -103.58% |
| Mar 31, 2023 | -99.06% |
| Dec 31, 2022 | -142.49% |
| Sep 30, 2022 | -116.34% |
| Jun 30, 2022 | 281.54% |
| Mar 31, 2022 | 2,407,103.00% |
| Jun 30, 2010 | -402.35% |
| Mar 31, 2010 | -100.03% |